Publications by authors named "John R Cook"

Claim this Profile
C
Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India.
John R Cook, Kunal Saxena, Catharine Taylor, Jeffrey L Jacobs

BMC Health Serv Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS/CoV-2: Behavioral Host Manipulation.
John R Cook, Kaylee V Bennett, Michael C Barton, Steven M Platek

Adv Exp Med Biol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infection.
Michael C Barton, Kaylee V Bennett, John R Cook, Gordon G Gallup, Steven M Platek

Med Hypotheses· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposed symptom-based model of the origins of schizophrenia.
John R Cook, Steven M Platek, Carlos N Espinoza

Med Hypotheses· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Merging regulatory and reimbursement needs in clinical trials.
John R Cook

Value Health· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.
Robbin F Itzler, Po Yen Chen, Christina Lac, Antoine C El Khoury, John R Cook

J Med Econ· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthy-days time equivalents for outcomes of acute rotavirus infections.
A Brett Hauber, Robbin Itzler, F Reed Johnson, Ateesha F Mohamed, Juan Marcos González, John R Cook

Vaccine· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries).
Timo Vesikari, Robbin Itzler, David O Matson, Mathuram Santosham, Celia D C Christie, John R Cook

Int J Infect Dis· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholesterol reduction yields clinical benefits: meta-analysis including recent trials.
A Lawrence Gould, Glenn M Davies, Evo Alemao, Donald D Yin, John R Cook

Clin Ther· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Projected coronary heart disease risk benefit with ezetimibe.
Glenn M Davies, John R Cook, John Erbey, Evo Alemao, Enrico P Veltri

Atherosclerosis· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a model to project the long-term benefit and cost of alternative lipid-lowering strategies in patients with hypercholesterolaemia.
John R Cook, Don Yin, Evo Alemao, Michael Drummond

Pharmacoeconomics· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of ezetimibe coadministration in statin-treated patients not at cholesterol goal: application to Germany, Spain and Norway.
John R Cook, Don Yin, Evo Alemao, Glenn Davies, Karl J Krobot

Pharmacoeconomics· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine.
Paul M Coplan, John R Cook, George W Carides, Joseph F Heyse, Albert W Wu

Clin Infect Dis· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the appropriateness of combining economic data from multinational clinical trials.
John R Cook, Michael Drummond, Henry Glick, Joseph F Heyse

Stat Med· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation.
William H Herman, Shahnaz Shahinfar, George W Carides, Erik J Dasbach, William C Gerth, John R Cook

Diabetes Care· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction.
Elizabeth M Mahoney, Claudine T Jurkovitz, Haitao Chu, Edmund R Becker, Steven Culler, John R Cook

JAMA· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis